Journal Articles

Guidelines/Reviews

 

CMAJ - May 04, 2020

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence based guideline

Z. Ye, et. al.

https://www.cmaj.ca/content/cmaj/early/2020/05/04/cmaj.200648.full.pdf

​

NIH - April 20, 2020

NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines

R. Gulick, H. Lane, H. Masur, et. al.

https://www.covid19treatmentguidelines.nih.gov/

​

IDSA - April 11, 2020

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

A. Bhimraj, et. al.

https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/

​

ICM - Mar 28, 2020

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

W. Alhazzani, et. al.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101866/

 

JAMA - Mar 11, 2020

Care for Critically Ill Patients With COVID-19

S. Murthy, et. al.

https://jamanetwork.com/journals/jama/fullarticle/2762996

​

​

Potential Therapies

​

NEJM - May 22, 2020

Remdesivir for the Treatment of Covid-19 — Preliminary Report

JH Beigel, et. al.

https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

​

Consider also:

PulmCrit - May 23, 2020

PulmCrit – Preliminary report on NIAID trial of remdesivir (ACTT-1)

Josh Farkas

https://emcrit.org/pulmcrit/actt-remdesivir/

​

Lancet - April 29, 2020

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Y. Wang, et. al.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2820%2931022-9/fulltext

 

Consider also:

PulmCrit - April 30, 2020

PulmCrit – First placebo-controlled RCT on remdesivir for COVID-19

Josh Farkas

https://emcrit.org/pulmcrit/wang-remdesivir/

​

medRxiv - April 14, 2020

Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial

W. Tang, et. al.

https://www.medrxiv.org/content/10.1101/2020.04.10.20060558v1.full.pdf+html

​

Consider also:

PulmCrit - April 16, 2020

PulmCrit – Hydroxychloroquine fails first meaningful RCT

Josh Farkas

https://emcrit.org/pulmcrit/hydroxychloroquine-fail/

​

NEJM - April 10, 2020

Compassionate Use of Remdesivir for Patients with Severe Covid-19

J. Grein, et. al.

https://www.nejm.org/doi/full/10.1056/NEJMoa2007016

​​

Consider also:

PulmCrit - April 11, 2020

PulmCrit – Eleven reasons the NEJM paper on remdesivir reveals nothing

Josh Farkas

https://emcrit.org/pulmcrit/pulmcrit-eleven-reasons-the-nejm-paper-on-remdesivir-reveals-nothing/

​

NEJM - March 18, 2020

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao, et. al.

https://www.nejm.org/doi/full/10.1056/NEJMoa2001282

​

Pathophysiology/Transmission

​

ICM - April 23, 2020

Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection

MC. Copin, et. al.

https://link.springer.com/content/pdf/10.1007%2Fs00134-020-06057-8.pdf

​

JAMA - March 4, 2020

Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient

SWX. Ong, et. al.

https://jamanetwork.com/journals/jama/fullarticle/2762692

​

Case Reports/Case Series

​

JAMA - April 22, 2020

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

S. Richardson, et. al.

https://jamanetwork.com/journals/jama/fullarticle/2765184

​

NEJM - April 17, 2020

Clinical Characteristics of Covid-19 in New York City (Correspondence)

P. Goyal, et. al.

https://www.nejm.org/doi/full/10.1056/NEJMc2010419

​

Resuscitation - April 6, 2020

In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China

F. Shao, et. al.

https://www.resuscitationjournal.com/article/S0300-9572%2820%2930142-8/pdf

​

JAMA - April 6, 2020

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

G. Grasselli, et. al.

https://jamanetwork.com/journals/jama/fullarticle/2764365

​

Lancet - Mar 28, 2020

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

F. Zhou, et. al.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext

​

NEJM - Feb 28, 2020

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan, et. al.

https://www.nejm.org/doi/full/10.1056/NEJMoa2002032

​